Rogers Erica J. 4
4 · Silk Road Medical Inc · Filed Apr 12, 2023
Insider Transaction Report
Form 4
Rogers Erica J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-04-11$39.77/sh−6,000$238,635→ 269,132 total - Exercise/Conversion
Option (right to buy)
2023-04-11−6,000→ 18,654 totalExercise: $1.60From: 2016-09-04Exp: 2026-08-04→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2023-04-11$1.60/sh+6,000$9,600→ 275,132 total
Holdings
- 83,843(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 8, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]This transaction was executed in multiple trades at price ranging from $39.12 to $40.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
- [F4]All of the shares subject to the option are fully vested and exercisable as of the date hereof.